["Type": "Thrombolytics Adverse Event"]
Performance/Reporting Period
2025
Value Set Description from VSAC
Clinical Focus: The purpose of this value set is to represent concepts for adverse reactions to thrombolytic medications used for treatment of ST-segment elevation myocardial infaction (STEMI).
Data Element Scope: This value set may use a model element related to Disorder.
Inclusion Criteria: Includes SNOMED-CT codes that represent adverse reactions to thrombolytic medications for STEMI treatment.
Exclusion Criteria: No exclusions.
Data Element Scope: This value set may use a model element related to Disorder.
Inclusion Criteria: Includes SNOMED-CT codes that represent adverse reactions to thrombolytic medications for STEMI treatment.
Exclusion Criteria: No exclusions.
Constrained to codes in the Thrombolytics Adverse Event value set (2.16.840.1.113762.1.4.1170.6)
QDM Datatype and Definition
type
The characterization of the reaction (e.g., hypersensitivity, rash, gastroenteric symptoms, etc.).
Last Updated: Jun 26, 2024